Standardization of 123I- meta-iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications
- PMID: 28596948
- PMCID: PMC5437131
- DOI: 10.1007/s40336-017-0230-2
Standardization of 123I- meta-iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications
Abstract
Purpose: Myocardial sympathetic imaging with 123I-meta-iodobenzylguanidine (123I-mIBG) has gained clinical momentum. Although the need for standardization of 123I-mIBG myocardial uptake has been recognized, the availability of practical clinical standardization approaches is limited. The need for standardization includes the heart-to-mediastinum ratio (HMR) and washout rate with planar imaging, and myocardial defect scoring with single-photon emission computed tomography (SPECT).
Methods: The planar HMR shows considerable variation due to differences in collimator design. These camera-collimator differences can be overcome by cross-calibration phantom experiments. The principles of these cross-calibration phantom experiments are summarized in this article. 123I-mIBG SPECT databases were compiled by Japanese Society of Nuclear Medicine working group. Literature was searched based on the words "123I-mIBG quantification method", "standardization", "heart-to-mediastinum ratio", and its application to "risk model".
Results: Calibration phantom experiments have been successfully performed in Japan and Europe. The benefit of these cross-calibration phantom experiments is that variation in the HMR between institutions is minimized including low-energy, low-medium-energy and medium-energy collimators. The use of myocardial 123I-mIBG SPECT can be standardized using 123I-mIBG normal databases as a basis for quantitative evaluation. This standardization method can be applied in cardiac event prediction models.
Conclusion: Standardization of myocardial 123I-mIBG outcome parameters may facilitate a universal implementation of myocardial 123I-mIBG scintigraphy.
Keywords: Calibration phantom; Collimator; Conversion coefficient; Heart-to-mediastinum ratio; Quantification.
Conflict of interest statement
Conflict of interest
K. Nakajima and K. Okuda have collaborative works to develop software with FUJIFILM RI Pharma, Co. Ltd, Tokyo, Japan.
Ethical approval and informed consent
Ethical approval and informed consent statements were shown in individual studies in references.
Figures






Similar articles
-
Cross calibration of 123I-meta-iodobenzylguanidine heart-to-mediastinum ratio with D-SPECT planogram and Anger camera.Ann Nucl Med. 2017 Oct;31(8):605-615. doi: 10.1007/s12149-017-1191-2. Epub 2017 Jul 8. Ann Nucl Med. 2017. PMID: 28689357 Free PMC article.
-
A European myocardial 123I-mIBG cross-calibration phantom study.J Nucl Cardiol. 2018 Aug;25(4):1191-1197. doi: 10.1007/s12350-017-0782-6. Epub 2017 Jan 24. J Nucl Cardiol. 2018. PMID: 28120154 Free PMC article.
-
Comparison of Taiwanese and European Calibration Factors for Heart-to-Mediastinum Ratio in Multicenter 123I-mIBG Phantom Studies.Ann Nucl Cardiol. 2023;9(1):54-60. doi: 10.17996/anc.23-00006. Epub 2023 Oct 31. Ann Nucl Cardiol. 2023. PMID: 38058572 Free PMC article.
-
Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database.Ann Nucl Med. 2016 Apr;30(3):188-99. doi: 10.1007/s12149-016-1065-z. Epub 2016 Feb 20. Ann Nucl Med. 2016. PMID: 26897008 Free PMC article. Review.
-
Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.J Nucl Med. 2015 Jun;56 Suppl 4:11S-19S. doi: 10.2967/jnumed.114.142794. J Nucl Med. 2015. PMID: 26033897 Review.
Cited by
-
The prognostic value of 123I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review.J Nucl Cardiol. 2022 Aug;29(4):1799-1809. doi: 10.1007/s12350-020-02501-w. Epub 2021 Jan 13. J Nucl Cardiol. 2022. PMID: 33442819 Free PMC article.
-
Machine learning-based prediction of conversion coefficients for I-123 metaiodobenzylguanidine heart-to-mediastinum ratio.J Nucl Cardiol. 2023 Aug;30(4):1630-1641. doi: 10.1007/s12350-023-03198-3. Epub 2023 Feb 5. J Nucl Cardiol. 2023. PMID: 36740650 Free PMC article.
-
Phase dyssynchrony and 123I-meta-iodobenzylguanidine innervation imaging towards standardization.J Nucl Cardiol. 2019 Apr;26(2):519-523. doi: 10.1007/s12350-017-1069-7. Epub 2017 Sep 18. J Nucl Cardiol. 2019. PMID: 28924738 No abstract available.
-
Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age.J Nucl Cardiol. 2021 Aug;28(4):1692-1701. doi: 10.1007/s12350-019-01887-6. Epub 2019 Sep 16. J Nucl Cardiol. 2021. PMID: 31529384
-
Is 123I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database.Ann Nucl Med. 2018 Apr;32(3):175-181. doi: 10.1007/s12149-018-1231-6. Epub 2018 Jan 15. Ann Nucl Med. 2018. PMID: 29333564 Free PMC article.
References
-
- Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging. 2008;35:535–546. doi: 10.1007/s00259-007-0639-3. - DOI - PubMed
-
- Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212–2221. doi: 10.1016/j.jacc.2010.01.014. - DOI - PubMed
-
- Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of 123I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging. 2013;6:772–784. doi: 10.1016/j.jcmg.2013.02.007. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical